Morgan Stanley’s AveXis, Inc. Common Stock AVXS Stock Holding History

Morgan Stanley’s Portfolio AVXS Stock Details AVXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-163,259	Closed	-$20.2M	–	6904
2018 Q1	$20.2M	Buy	163,259 +31,937	+24%	+$3.8M	0.01%	1653
2017 Q4	$14.5M	Buy	131,322 +89,395	+213%	+$8.97M	﹤0.01%	2002
2017 Q3	$4.05M	Sell	41,927 -70,191	-63%	-$6.33M	﹤0.01%	3191
2017 Q2	$9.21M	Buy	112,118 +89,437	+394%	+$6.71M	﹤0.01%	2254
2017 Q1	$1.72M	Buy	22,681 +1,758	+8%	+$109K	﹤0.01%	3933
2016 Q4	$998K	Sell	20,923 -3,413	-14%	-$182K	﹤0.01%	4464
2016 Q3	$1M	Buy	24,336 +11,677	+92%	+$444K	﹤0.01%	4035
2016 Q2	$481K	Buy	12,659 +12,335	+3,807%	+$417K	﹤0.01%	4445
2016 Q1	$9K	Buy	+324	New	+$7.08K	﹤0.01%	6165

Other funds holding AVXS

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Morgan Stanley's AVXS Position: Q2 2018 in Review

Morgan Stanley sold out of AveXis, Inc. Common Stock (AVXS) in Q2 2018, closing a stake of 163,259 shares — an estimated $20.2M sold.

Morgan Stanley first reported a position in AVXS in Q1 2016 and held it in 9 quarters. The position peaked at $20.2M in Q1 2018. 1 fund tracked by Wall St. Rank holds AVXS as of Q2 2018.

Morgan Stanley reported no remaining AveXis, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Morgan Stanley sold 163,259 AveXis, Inc. Common Stock shares in Q2 2018, an estimated $20.2M.
Morgan Stanley first reported a position in AveXis, Inc. Common Stock in Q1 2016 and held it in 9 quarters.
Morgan Stanley's AveXis, Inc. Common Stock position peaked at $20.2M in Q1 2018.
1 fund tracked by Wall St. Rank held AveXis, Inc. Common Stock as of Q2 2018.

Based on Morgan Stanley's 13F filing for Q2 2018, filed 14 Aug 2018.